A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8(+) T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma

Tailored treatment for patients with rectal cancer requires clinically available markers to predict their response to neoadjuvant treatment. The quantity of tumor-infiltrating lymphocytes (TILs) in pre-operative tumor biopsies has been suggested to predict a favorable response, but opposing results...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezapour, Azar, Rydbeck, Daniel, Byvald, Fabian, Tasselius, Viktor, Danielsson, Gustaf, Angenete, Eva, Yrlid, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173792/
https://www.ncbi.nlm.nih.gov/pubmed/37180638
http://dx.doi.org/10.1080/2162402X.2023.2209473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173792/
https://www.ncbi.nlm.nih.gov/pubmed/37180638
http://dx.doi.org/10.1080/2162402X.2023.2209473

Ejemplares similares